EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.


Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
01 2019
Historique:
received: 11 07 2018
accepted: 16 07 2018
pubmed: 22 7 2018
medline: 21 3 2020
entrez: 21 7 2018
Statut: ppublish

Résumé

Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR.

Identifiants

pubmed: 30028512
doi: 10.1111/all.13562
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-27

Informations de copyright

© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Auteurs

Knut Brockow (K)

Department of Dermatology und Allergology Biederstein, Technical University of Munich, Munich, Germany.

Michael R Ardern-Jones (MR)

Department of Dermatology, Southampton General Hospital, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.
Department of Dermatoimmunology, Sir Henry Wellcome Laboratories, Clinical, Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Maja Mockenhaupt (M)

"Dokumentationszentrum schwerer Hautreaktionen" (dZh), Department of Dermatology, Medical Center and Medical Faculty, University of Freiburg, Freiburg, Germany.

Werner Aberer (W)

Department of Dermatology, Medical University of Graz, Graz, Austria.

Annick Barbaud (A)

Department of Dermatology and Allergology, Tenon Hospital (AP-HP), Sorbonne Universities, Pierre et Marie Curie University, Paris 6, France.

Jean-Christoph Caubet (JC)

Pediatric Allergology Unit, Geneva University Hospitals, Geneva, Switzerland.

Radoslaw Spiewak (R)

Department of Experimental Dermatology and Cosmetology, Jagiellonian University Medical College, Krakow, Poland.

María José Torres (MJ)

Allergy Unit, IBIMA- Regional University Hospital of Malaga-UMA, Aradyal, Malaga, Spain.

Charlotte G Mortz (CG)

Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), Odense University Hospital, Odense, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH